Skip to main content
. Author manuscript; available in PMC: 2015 Jul 15.
Published in final edited form as: Cancer. 2014 Apr 15;120(14):2142–2149. doi: 10.1002/cncr.28705

Figure 1. Survival Curves.

Figure 1

A: Overall Survival from beginning of treatment (Median 6 months), B: Overall Survival from FLT3 Inhibitor treatment discontinuation (Median 3 months), C: Survival Patients Transplanted (Median 7 Months), D: Survival Patients with Undetectable Mutation After Treatment (Median 7 months), E: Survival Patients with Unchanged Mutation Status (Median 5 months), F: Survival Patients Developing Both Mutations (Median 7 months).